Segall Bryant & Hamill LLC bought a new position in Chemed Co. (NYSE:CHE – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 24,311 shares of the company’s stock, valued at approximately $12,880,000.
Other large investors have also added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in shares of Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after buying an additional 39 shares during the period. Atala Financial Inc bought a new position in Chemed in the fourth quarter valued at about $29,000. CBIZ Investment Advisory Services LLC boosted its position in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after purchasing an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new stake in shares of Chemed during the 4th quarter valued at about $34,000. Finally, Tortoise Investment Management LLC increased its position in shares of Chemed by 77.3% during the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.
Chemed Stock Up 0.3 %
Shares of CHE opened at $608.54 on Wednesday. The business has a 50-day simple moving average of $570.74 and a two-hundred day simple moving average of $565.85. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $646.71. The stock has a market cap of $8.91 billion, a price-to-earnings ratio of 30.75, a PEG ratio of 2.15 and a beta of 0.43.
Chemed Dividend Announcement
Insiders Place Their Bets
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Brian C. Judkins bought 145 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of equities analysts recently issued reports on CHE shares. Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.
Read Our Latest Research Report on Chemed
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Compound Interest and Why It Matters When Investing
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.